Advancements in Diagnosis and Management of Cardiomyopathies: Bridging Basic Science to Personalized Therapy

Dear Colleagues,

Cardiomyopathy represents a complex group of heart muscle diseases that significantly impact global health. Recent advancements in both diagnosis and management have revolutionized our understanding of cardiomyopathy and its treatment strategies. This proposed Special Issue aims to explore the latest developments in the field, spanning from basic science to the application of personalized therapies.

This Special Issue will encompass a wide array of topics related to cardiomyopathy, including, but not limited to, the following:

• Genetic insights: Exploration of genetic mechanisms underlying various forms of cardiomyopathy, including hypertrophic, dilated, and restrictive cardiomyopathies.
• Diagnostic innovations: Novel imaging techniques, biomarkers, and genetic testing approaches for early diagnosis and phenotyping of cardiomyopathy.
• Pathophysiological mechanisms: Understanding the molecular and cellular pathways implicated in the development and progression of cardiomyopathy.
• Emerging therapeutic strategies: Evaluation of pharmacological interventions, gene therapies, and device-based approaches for managing cardiomyopathy.
• Precision medicine approaches: Application of personalized medicine paradigms to tailor treatment strategies based on individual patient characteristics and genetic profiles.
• Clinical management challenges: Addressing clinical dilemmas and optimizing the management of cardiomyopathy across different patient populations.

Manuscripts submitted to this Special Issue should present original research findings, comprehensive reviews, or perspective articles that contribute to the advancement of knowledge in the field of cardiomyopathy. All submissions will undergo rigorous peer review to ensure scientific integrity and relevance to the theme of this Special Issue.

Dr. Emanuele Monda
Dr. Giuseppe Limongelli
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• cardiomyopathy
• diagnosis
• management
• basic science
• personalized therapy
• myocardial disease
• cardiovascular disease
• congenital heart disease